Moreno-Fernandez J., Chico A., Martínez-Brocca M.A., Beato-Víbora P.I., Vidal M., Piedra M., Quirós C., Muñoz-Rodríguez J.R.. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Diabetes Technology & Therapeutics. 2022; 24(12)DOI:10.1089/dia.2022.0207. PMID:35947087. IF:5.400(Q1/3D).

Casas J.A.V., Sambo M., López C.L., Durán-Poveda M., García J.R.-V., Santos R.J., Llanos M., Navarro-González E., Aller J., Pubul V., Guadalix S., Crespo G., González C., Zafón C., Navarro M., Santamaría-Sandi J., Segura Á., Gajate P., Gómez-Balaguer M., Valdivia J., Puig-Domingo M., Galofré J.C., Castelo B., Villanueva M.J., Argüelles I., Orcajo-Rincón L.. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. European Thyroid Journal. 2022; 11(5)DOI:10.1530/ETJ-21-0111. PMID:35900793. IF:4.700(Q2/3D).

Pérez Pérez A., Ortega Martínez de Victoria E., Arrieta Blanco F., Caixàs Pedragós A., Santos Mazo E., Fernández-Catalina P., Martínez-Hervas S., López-Medina J.A., Suárez-Gutiérrez L., Urgeles Planelles J.R., Gatell Menchén S., Tinahones Madueño F.. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7)DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1.900(Q4/9D).

Tomic D., Morton J.I., Chen L., Salim A., Gregg E.W., Pavkov M.E., Arffman M., Balicer R., Baviera M., Boersma-van Dam E., Brinks R., Carstensen B., Chan J.C.N., Cheng Y.J., Fosse-Edorh S., Fuentes S., Gardiner H., Gulseth H.L., Gurevicius R., Ha K.H., Hoyer A., Jermendy G., Kautzky-Willer A., Keskimäki I., Kim D.J., Kiss Z., Klimek P., Leventer-Roberts M., Lin C.-Y., Lopez-Doriga Ruiz P., Luk A.O.Y., Ma S., Mata-Cases M., Mauricio D., McGurnaghan S., Imamura T., Paul S.K., Peeters A., Pildava S., Porath A., Robitaille C., Roncaglioni M.C., Sugiyama T., Wang K.-L., Wild S.H., Yekutiel N., Shaw J.E., Magliano D.J.. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11)DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44.500(Q1/1D).

van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).

Rivero-Sanchez, L, Gavric, A, Herrero, J, Remedios, D, Alvarez, V, Albeniz, E, Gordillo, J, Puig, I, Lopez-Vicente, J, Huerta, A, Lopez-Ceron, M, Salces, I, Penas, B, Parejo, S, Rodriguez, E, Herraiz, M, Carretero, C, Gimeno-Garcia, AZ, Saperas, E, Alvarez, C, Arnau-Collell, C, Ortiz, O, Sanchez, A, Jung, G, Balaguer, F, Pellise, M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. ENDOSCOPY. 2022; 54(01)DOI:10.1055/a-1328-5405. PMID:33271604. IF:9.300(Q1/1D).